Relationship of ethnicity and overall survival (OS) in Asian patients (pts) on sorafenib for advanced hepatocellular carcinoma (HCC) in British Columbia, Canada

被引：0
|
作者：
Peixoto, Renata D'Alpino [1 ]
Renouf, Daniel John [1 ]
Gill, Sharlene [1 ]
Cheung, Winson Y. [1 ]
Kennecke, Hagen F. [1 ]
Lim, Howard John [1 ]
机构：
[1] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 03期
关键词：
D O I：
10.1200/jco.2014.32.3_suppl.311
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
311
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Correlation between overall survival (OS) and time to progression (TTP) and between OS and response rate (RR) by RECIST in advanced hepatocellular carcinoma (HCC)
    Huang, L.
    De Sanctis, Y.
    Shan, M.
    Bruix, J.
    Llovet, J. M.
    Cheng, A-L.
    Meinhardt, G.
    Nakajima, K.
    ANNALS OF ONCOLOGY, 2017, 28
  • [22] Factors Contributing to the Overall Survival in Patients with Hepatocellular Carcinoma Treated by Sorafenib
    Tsukui, Yuya
    Mochizuki, Hitoshi
    Hoshino, Yuji
    Kawakami, Satoshi
    Kuno, Toru
    Fukasawa, Yoshimitsu
    Iwamoto, Fumihiko
    Hirose, Sumio
    Yoshida, Takashi
    Hosoda, Kenji
    Suzuki, Youji
    Hosoda, Kazuhiko
    Kojima, Yuichiro
    Hirose, Yuichi
    Shindou, Kuniaki
    Matsuda, Masanori
    Yagawa, Syoji
    Tawara, Akio
    Kobayashi, Masashi
    Konishi, Toshiyuki
    Yamazaki, Takahisa
    Takahashi, Seiichiro
    Fujii, Hideki
    Enomoto, Nobuyuki
    Omata, Masao
    HEPATO-GASTROENTEROLOGY, 2012, 59 (120) : 2536 - 2539
  • [23] Overall survival (OS) by platelet count at baseline in patients with hepatocellular carcinoma (HCC) treated with sorafenib (SOR) in the SHARP and AP trials and regorafenib (REG) in the RESORCE trial
    Meinhardt, G.
    De Sanctis, Y.
    LeBerre, M-A.
    Nakajima, K.
    ANNALS OF ONCOLOGY, 2017, 28
  • [24] Overall Survival in Patients with Hepatocellular Carcinoma Treated with Sorafenib: A Polish Experience
    Stras, Wojciech
    Gotlib, Joanna
    Malkowski, Piotr
    Wasiak, Dariusz
    Sliwczynski, Andrzej
    Panczyk, Mariusz
    Tronina, Olga
    Brzozowska, Melania
    MEDICAL SCIENCE MONITOR, 2021, 27
  • [25] Efficacy and Safety of Nivolumab in Asian Patients (Pts) With Advanced Hepatocellular Carcinoma (HCC): Subanalysis of the CheckMate 040 Study
    Kudo, Masatoshi
    Hsu, Chiun
    Kim, Tae-You
    Choo, Su-Pin
    Kang, Yoon-Koo
    Hou, Ming-Mo
    Yeo, Winnie
    Numata, Kazushi
    Chopra, Akhil
    Baakili, Adyb
    dela Cruz, Christine
    Zhao, Huanyu
    Yau, Thomas
    ANNALS OF ONCOLOGY, 2017, 28
  • [26] Phase I study of tramatinib combined with sorafenib in patients (pts) with advanced hepatocellular cancer (HCC).
    Wang, Emilie
    Kim, Dae Won
    Mahipal, Amit
    Chen, Dung-Tsa
    Cao, Biwei
    Masawi, Fadzai
    Kim, Richard D.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [27] The impact of patient and tumour baseline characteristics on the overall survival of patients with advanced hepatocellular carcinoma treated with sorafenib
    Woerns, Marcus A.
    Koch, Sandra
    Niederle, Ina M.
    Marquardt, Jens U.
    Nguyen-Tat, Marc
    Gamstaetter, Thomas
    Schuchmann, Marcus
    Schulze-Bergkamen, Henning
    Galle, Peter R.
    Weinmann, Arndt
    DIGESTIVE AND LIVER DISEASE, 2013, 45 (05) : 408 - 413
  • [28] Doxorubicin and sorafenib improves survival in patients with advanced hepatocellular carcinoma
    Lisa Hutchinson
    Nature Reviews Clinical Oncology, 2011, 8 (2) : 61 - 61
  • [29] A phase I study of bavituximab and sorafenib in patients with advanced hepatocellular carcinoma (HCC)
    Yopp, Adam
    Arriega, Yuii
    Singal, Amit
    Mansour, John
    Bach, Glen
    Thorpe, Phillip
    CANCER RESEARCH, 2012, 72
  • [30] Sorafenib (S) in patients (pts) with advanced hepatocellular carcinoma (HCC): Safety and efficacy in Child-Pugh (CP) class A and B patients
    Pressiani, Tiziana
    Boni, Corrado
    Rimassa, Lorenza
    Labianca, Roberto
    Fagiuoli, Stefano
    Ardizzoni, Andrea
    Foa, Paolo
    Cortesi, Enrico
    Giordano, Laura
    Santoro, Armando
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
12345